All the talk for a while was when was NVDA going to split? Well, it as well as CMG are finally happening. What about LLY? They have split 4 times at 2/1 but last was a 1997. I keep hearing the stock is expensive- P/E 119. GLP -1 drugs have incredible growth potential as more uses other than weight loss get discovered (cardio protective, renal protective). Yes they have competition in NVO but LLY has huge cash flow and just announced another 5 billion for production of more GLP-1 meds. Is a split coming???
And the “it’s still the same percentage of the company per dollar amount regardless of share price” crap gets old. Just like NVDA, more retail investors will buy in to get whole shares I think.
Leave a Reply